Valion Bio Evaluates Options After Unsolicited Acquisition Inquiries
Valion Bio received unsolicited acquisition inquiries for Velocity Bioworks and is evaluating strategic options, including a possible sale.
Story updates
12:05:17 PM UTC
SquawkNews
Valion Bio said it received unsolicited acquisition inquiries for its CDMO subsidiary, Velocity Bioworks, and has begun preliminary talks while reviewing strategic options. It hired an investment bank and emphasized retaining manufacturing access for Entolimod.Material DetailsContext by AI AnalystT…
Valion Bio received unsolicited acquisition inquiries for Velocity Bioworks and is evaluating strategic options, including a possible sale.Key Highlights:Original SEC Filing: Valion Bio, Inc. [ VBIO ] - 8-K - Oct. 26, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider verifyin…